Display options
Share it on

Neurol Clin Pract. 2017 Jun;7(3):194-204. doi: 10.1212/CPJ.0000000000000358.

Early transition to comfort measures only in acute stroke patients: Analysis from the Get With The Guidelines-Stroke registry.

Neurology. Clinical practice

Shyam Prabhakaran, Margueritte Cox, Barbara Lytle, Phillip J Schulte, Ying Xian, Darin Zahuranec, Eric E Smith, Mathew Reeves, Gregg C Fonarow, Lee H Schwamm

Affiliations

  1. Feinberg School of Medicine (SP), Northwestern University, Chicago, IL; Duke Clinical Research Institute (MC, BL, PJS, YX), Durham, NC; University of Michigan (DZ), Ann Arbor; Hotchkiss Brain Institute (EES), University of Calgary, Canada; Michigan State University (MR), East Lansing; Ahmanson Cardiomyopathy Center (GCF), UCLA, Los Angeles, CA; Stroke Service (LHS), Massachusetts General Hospital, Boston; and Duke University Medical Center (YX), Durham, NC.

PMID: 28680764 PMCID: PMC5490382 DOI: 10.1212/CPJ.0000000000000358

Abstract

BACKGROUND: Death after acute stroke often occurs after forgoing life-sustaining interventions. We sought to determine the patient and hospital characteristics associated with an early decision to transition to comfort measures only (CMO) after ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) in the Get With The Guidelines-Stroke registry.

METHODS: We identified patients with IS, ICH, or SAH between November 2009 and September 2013 who met study criteria. Early CMO was defined as the withdrawal of life-sustaining treatments and interventions by hospital day 0 or 1. Using multivariable logistic regression, we identified patient and hospital factors associated with an early (by hospital day 0 or 1) CMO order.

RESULTS: Among 963,525 patients from 1,675 hospitals, 54,794 (5.6%) had an early CMO order (IS: 3.0%; ICH: 19.4%; SAH: 13.1%). Early CMO use varied widely by hospital (range 0.6%-37.6% overall) and declined over time (from 6.1% in 2009 to 5.4% in 2013;

CONCLUSIONS: Early CMO was utilized in about 5% of stroke patients, being more common in ICH and SAH than IS. Early CMO use varies widely between hospitals and is influenced by patient and hospital characteristics.

References

  1. Stroke. 2014 Nov;45(11):3243-50 - PubMed
  2. Stroke. 2012 May;43(5):1323-30 - PubMed
  3. Neurocrit Care. 2014 Aug;21(1):14-9 - PubMed
  4. Neurocrit Care. 2009 Dec;11(3):345-52 - PubMed
  5. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):243-52 - PubMed
  6. Crit Care Med. 2016 Jun;44(6):1161-72 - PubMed
  7. Neurocrit Care. 2013 Dec;19(3):342-6 - PubMed
  8. J Am Heart Assoc. 2013 Jan 28;2(1):e005207 - PubMed
  9. Neurology. 1995 Apr;45(4):634-40 - PubMed
  10. Neurology. 2012 Nov 6;79(19):1990-6 - PubMed
  11. Neurology. 2012 Aug 28;79(9):941-4 - PubMed
  12. Stroke. 2014 Jun;45(6):1887-916 - PubMed
  13. Int J Stroke. 2016 Apr;11(3):321-31 - PubMed
  14. World Neurosurg. 2014 Nov;82(5):e579-84 - PubMed
  15. Neurohospitalist. 2016 Jan;6(1):7-10 - PubMed
  16. Stroke. 2002 May;33(5):1225-32 - PubMed
  17. Stroke. 2014 Mar;45(3):822-7 - PubMed
  18. Stroke. 2001 Apr;32(4):891-7 - PubMed
  19. Neurology. 2001 Mar 27;56(6):766-72 - PubMed
  20. Neurology. 2015 Apr 28;84(17):1739-44 - PubMed
  21. BMC Palliat Care. 2013 May 10;12:21 - PubMed
  22. Stroke. 2004 May;35(5):1130-4 - PubMed
  23. Int J Stroke. 2014 Jan;9(1):53-8 - PubMed
  24. Lancet. 1996 May 18;347(9012):1415 - PubMed
  25. Am Heart J. 2012 Mar;163(3):392-8, 398.e1 - PubMed
  26. Acta Neurochir (Wien). 2015 Dec;157(12):2051-9 - PubMed
  27. Circulation. 2011 Feb 22;123(7):739-49 - PubMed
  28. Neurology. 2013 Jul 30;81(5):448-55 - PubMed
  29. Med Care. 2005 Jul;43(7):658-66 - PubMed
  30. J Palliat Med. 2008 Nov;11(9):1249-57 - PubMed
  31. Neurology. 2007 May 15;68(20):1651-7 - PubMed
  32. Stroke. 2000 Feb;31(2):448-55 - PubMed
  33. Arch Intern Med. 1997 Sep 8;157(16):1841-7 - PubMed
  34. Med Care. 2013 Dec;51(12):1094-100 - PubMed

Publication Types